About Elidah
Elidah is a company based in Monroe (United States) founded in 2014 by Gloria Kolb and Eric Kolb. Elidah has raised $2.02 million across 3 funding rounds from investors including America’s Seed Fund and National Science Foundation. Elidah offers products and services including Elitone and Elitone URGE. Elidah operates in a competitive market with competitors including Axonics, Amber Therapeutics, NeuSpera Medical, UroMems and Chiaro, among others.
- Headquarter Monroe, United States
- Founders Gloria Kolb, Eric Kolb
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.02 M (USD)
in 3 rounds
-
Latest Funding Round
$2.02 M (USD), Seed
Jun 02, 2023
-
Investors
America’s Seed Fund
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elidah
Elidah offers a comprehensive portfolio of products and services, including Elitone and Elitone URGE.
External device for treating stress urinary incontinence effectively.
Device designed for managing urge urinary incontinence daily.
People of Elidah
Unlock access to complete
Unlock access to complete
Funding Insights of Elidah
Elidah has successfully raised a total of $2.02M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.02 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Elidah
Elidah has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include America’s Seed Fund and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Elidah
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elidah
Investment portfolio details for Elidah
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elidah
Detailed financials for Elidah
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elidah Comparisons
Peer comparison for Elidah
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elidah
Elidah operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Amber Therapeutics, NeuSpera Medical, UroMems and Chiaro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| Locked | Locked | Locked |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| Locked | Locked | Locked |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| Locked | Locked | Locked |
Developer of active implantable devices for urological incontinence
|
|
| Locked | Locked | Locked |
Devices for pelvic floor muscle strengthening are developed by Chiaro.
|
|
| Locked | Locked | Locked |
An implantable device for the treatment of urinary incontinence stress
|
Detailed competitors of Elidah
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elidah
Complete news archive for Elidah
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elidah
Elidah was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Elidah is headquartered in Monroe, United States.
Gloria Kolb is the current CEO of Elidah. They have also founded this company.
Elidah is a funded company, having raised a total of $2.02M across 3 funding rounds to date.
Elidah was founded in 2014 and is based in Monroe, United States. A non-invasive, discreet wearable device is provided for home use to stimulate and strengthen pelvic floor muscles. Urinary incontinence is addressed through this technology, which avoids vaginal insertion. Operations focus on health technology for womens pelvic health, with development led by co-founders Gloria Kolb as CEO and Eric Kolb as CTO.
Elidah's top competitors include Axonics, NeuSpera Medical and Amber Therapeutics.
Elidah offers Elitone and Elitone URGE.
Elidah has 2 investors. Key investors include America’s Seed Fund, and National Science Foundation.